treatment options for transplant-ineligibile hl patients
Published 2 years ago • 47 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:18
evolving treatment options in ndmm: transplant-eligible and transplant-ineligible patients
-
1:16
treatment options for transplant-ineligible lymphoma patients: the growing role of immunotherapies
-
4:59
frontline treatment of transplant-ineligible mm: a changing landscape
-
3:40
master class in transplantation and hematology: highlights
-
1:33
sorafenib as maintenance therapy for patients with transplant-ineligible or post-allosct aml
-
1:47
shared treatment decision-making
-
2:13
frontline treatment of transplant eligible patients with myeloma: current approach & future changes
-
1:13
efficacy of transplantation in hl
-
1:05
optimizing the treatment of transplant-eligible ndmm: using quadruplets in induction & consolidation
-
2:38
ibrutinib treatment for cll does not increase the incidence of richter’s transformation
-
4:02
treatment-free intervals: what is best for patients?
-
1:27
transplantation – now considered as part of a treatment package
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
5:18
upfront treatment in transplant candidates
-
1:43
the addition of immunotherapy to the front-line treatment of as hodgkin lymphoma
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
2:04
the importance of individualizing treatment approaches in hl to improve patient outcomes
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:09
heart transplantation in attr amyloidosis